Core--Chemical
Core--Chemical
批准号:
6410518
负责人:
DAVID TRENTHAM
金额:
$39.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-01-01 至 2001-12-31
中文摘要
化学核心的长期目标和具体目标是为探索平滑肌生理学和细胞生物学机制提供独特的荧光和光敏“笼状”核苷酸资源。与本计划项目相关的研究的具体健康益处在导言(意义)和各个项目中列出。核心将主要通过以下方式实现其目标:(1)合成香豆素标记的核苷酸,这将能够识别交联状态并测量其形成和衰减速率;(2)合成新型笼状核苷酸和平滑肌调节剂,包括笼状磷酸化肌球蛋白调节轻链。实现这些目标的方法将是通过在主要研究人员的实验室中建立的化学协议。该合成化学计划将得到探针(通过监测其与分离的肌肉蛋白相互作用时的活性和功能)和笼状化合物(通过监测其光化学性质和(理想的)生物惰性)的严格表征的支持。进一步的目标将通过开发Pi和ADP的实时探针来实现,所述探针将用于(项目1)记录各种生理状态下的平滑肌ATP酶活性和伪ATP酶(肌球蛋白轻链激酶/平滑肌磷酸酶)活性。最后,在实际的范围内,通过探测试剂在去皮骨骼肌纤维中的行为,在生理环境中测试试剂。NIMR物理生物化学部的化学家,酶学家和生理学家的专业知识和合作使其成为独特的化学核心设施。
英文摘要
The Chemical Core has the long term objective and specific aim of providing a unique resource of fluorescent and photosensitive "caged" nucleotides for exploring mechanisms of smooth muscle physiology and cell biology. The specific health benefits of the research relevant to this program project are set out in the Introduction (Significance" and in the individual projects. The Core will achieve its goals principally through (1) synthesis of coumarin-labeled nucleotides that will enable crossbridge states to be identified and their rates of formation and decay measured; (2) the synthesis of novel caged nucleotides and regulators of smooth muscle including caged phosphorylated myosin regulatory light chains. The methods for achieving these goals will be through chemical protocols established in the laboratories of the principal investigators. This synthetic chemistry program will be supported by rigorous characterization of the probes (by monitoring their activity and function when interacting with isolated muscle proteins) and the caged compounds (by monitoring their photochemical properties and (desirable) biological inertness). Further goals will be achieved by development of real-time probes of Pi and ADP that will be applied (Project 1) to record smooth muscle ATPase activity in various physiological states and pseudo- ATPase (myosin light chain kinase/smooth muscle phosphatase) activity. Finally, the reagents will, insofar as is practical, be tested in a physiological environment by probing their behavior in skinned skeletal muscle fibers. The expertise and collaboration of chemists, enzymologists and physiologists in the Division of Physical Biochemistry at NIMR make this a unique chemical core facility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core--Chemical
-
批准号:6564810
-
项目类别:
-
资助金额:$39.96万
-
财政年份:2002
-
负责人:DAVID TRENTHAM
-
依托单位:
COMPARISON OF ORAL COLLORAL WITH PLACEBO IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
-
批准号:6118929
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:DAVID TRENTHAM
-
依托单位:
OPEN LABEL STUDY OF ORAL TYPE II COLLAGEN IN JUVENILE RHEUMATOID ARTHRITIS
-
批准号:6118900
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:DAVID TRENTHAM
-
依托单位:
OPEN LABEL STUDY OF ORAL TYPE II COLLAGEN IN JUVENILE RHEUMATOID ARTHRITIS
-
批准号:6250109
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:DAVID TRENTHAM
-
依托单位:
THERAFECTIN COMPARED TO PLACEBO IN PATIENTS WITH RHEUMATOID ARTHRITIS
-
批准号:6250157
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:DAVID TRENTHAM
-
依托单位:
OPEN LABEL STUDY OF ORAL TYPE II COLLAGEN IN JUVENILE RHEUMATOID ARTHRITIS
-
批准号:6279920
-
项目类别:
-
资助金额:$2.49万
-
财政年份:1997
-
负责人:DAVID TRENTHAM
-
依托单位:
COMPARISON OF ORAL COLLORAL WITH PLACEBO IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
-
批准号:6279949
-
项目类别:
-
资助金额:$2.49万
-
财政年份:1997
-
负责人:DAVID TRENTHAM
-
依托单位:
THERAFECTIN COMPARED TO PLACEBO IN PATIENTS WITH RHEUMATOID ARTHRITIS
-
批准号:6279948
-
项目类别:
-
资助金额:$2.49万
-
财政年份:1997
-
负责人:DAVID TRENTHAM
-
依托单位:
COMPARISON OF ORAL COLLORAL WITH PLACEBO IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
-
批准号:6250158
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:DAVID TRENTHAM
-
依托单位:
MIRA - MINOCYCLINE IN RHEUMATOID ARTHRITIS
-
批准号:2298280
-
项目类别:
-
资助金额:$7.1万
-
财政年份:1991
-
负责人:DAVID TRENTHAM
-
依托单位:
MIRA - MINOCYCLINE IN RHEUMATOID ARTHRITIS
-
批准号:2298281
-
项目类别:
-
资助金额:$11.28万
-
财政年份:1991
-
负责人:DAVID TRENTHAM
-
依托单位:
MIRA - MINOCYCLINE IN RHEUMATOID ARTHRITIS
-
批准号:2298284
-
项目类别:
-
资助金额:$12.69万
-
财政年份:1991
-
负责人:DAVID TRENTHAM
-
依托单位:
MIRA - MINOCYCLINE IN RHEUMATOID ARTHRITIS
-
批准号:2298282
-
项目类别:
-
资助金额:$1.16万
-
财政年份:1991
-
负责人:DAVID TRENTHAM
-
依托单位:
MIRA - MINOCYCLINE IN RHEUMATOID ARTHRITIS
-
批准号:2298283
-
项目类别:
-
资助金额:$28.67万
-
财政年份:1991
-
负责人:DAVID TRENTHAM
-
依托单位:
MIRA - MINOCYCLINE IN RHEUMATOID ARTHRITIS
-
批准号:2298285
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1991
-
负责人:DAVID TRENTHAM
-
依托单位:
Therafectin compared to placebo in patients with rheumatoid arthritis
-
批准号:6286468
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1977
-
负责人:DAVID TRENTHAM
-
依托单位:
Core--Chemical
-
批准号:6315119
-
项目类别:
-
资助金额:$39.96万
-
财政年份:1977
-
负责人:DAVID TRENTHAM
-
依托单位:
COMPARISON OF ORAL COLLORAL WITH PLACEBO IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
-
批准号:6355273
-
项目类别:
-
资助金额:$19.39万
-
财政年份:--
-
负责人:DAVID TRENTHAM
-
依托单位:
Therafectin compared to placebo in patients with rheumatoid arthritis
-
批准号:6355239
-
项目类别:
-
资助金额:$19.39万
-
财政年份:--
-
负责人:DAVID TRENTHAM
-
依托单位:
COMPARISON OF ORAL COLLORAL WITH PLACEBO IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
-
批准号:6339096
-
项目类别:
-
资助金额:$19.39万
-
财政年份:--
-
负责人:DAVID TRENTHAM
-
依托单位:
海外基金